Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19

No statistical sample size calculation was performed a priori, and sample size was equal to the number of patients treated during the study period. Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa J-M, Bretagne S. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care (London, England) England), 2021-09, Vol.25 (1), p.348-348, Article 348
Hauptverfasser:	Razazi, Keyvan, Arrestier, Romain, Haudebourg, Anne Fleur, Botterel, Francoise, Mekontso Dessap, Armand
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute respiratory distress syndrome Aged Comorbidity Complications and side effects Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - virology Critical care Diagnosis Distribution Female Humans Influenza Life Sciences Male Middle Aged Mortality Opportunistic Infections - epidemiology Opportunistic Infections - microbiology Patients Pneumocystis carinii Pneumocystis carinii pneumonia Pneumonia Pneumonia, Pneumocystis - epidemiology Pneumonia, Pneumocystis - microbiology Pneumonia, Pneumocystis - virology Prevalence Research Letter Respiratory distress syndrome Respiratory Distress Syndrome - epidemiology Respiratory Distress Syndrome - microbiology Respiratory Distress Syndrome - virology Retrospective Studies Risk Factors Sample size SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	No statistical sample size calculation was performed a priori, and sample size was equal to the number of patients treated during the study period. Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa J-M, Bretagne S. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium.
ISSN:	1364-8535 1466-609X 1364-8535 1366-609X
DOI:	10.1186/s13054-021-03767-3